Action Point Financial Planning’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
Other funds holding BBH
Action Point Financial Planning's BBH Position: Q3 2026 in Review
Action Point Financial Planning sold out of VanEck Biotech ETF (BBH) in Q3 2026, closing a stake of 1 share — an estimated $203 sold.
Action Point Financial Planning first reported a position in BBH in Q2 2026 and held it in 1 quarter. The position peaked at $203 in Q2 2026. 122 funds tracked by Wall St. Rank hold BBH as of Q3 2026.
- Action Point Financial Planning reported no remaining VanEck Biotech ETF position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 1 VanEck Biotech ETF share in Q3 2026, an estimated $203.
- Action Point Financial Planning first reported a position in VanEck Biotech ETF in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's VanEck Biotech ETF position peaked at $203 in Q2 2026.
- 122 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.